Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.
暂无分享,去创建一个
Charis Eng | Andrea Frilling | Frank Weber | C. Morrison | C. Eng | M. Saji | M. Ringel | C. Broelsch | F. Weber | M. Aldred | A. Frilling | Christoph E Broelsch | Motoyasu Saji | Matthew D Ringel | Carl D Morrison | Micheala A Aldred | Lei Shen | F. Schuppert | Lei Shen | Frank Schuppert
[1] N. Lee,et al. Silencing of Wnt Signaling and Activation of Multiple Metabolic Pathways in Response to Thyroid Hormone-Stimulated Cell Proliferation , 2001, Molecular and Cellular Biology.
[2] Grace C H Yang,et al. Should cytopathologists stop reporting follicular neoplasms on fine‐needle aspiration of the thyroid? , 2003, Cancer.
[3] G. Brabant,et al. Identification of a Wnt/β-Catenin Signaling Pathway in Human Thyroid Cells. , 2001, Endocrinology.
[4] M. Tötsch,et al. Expression of Galectin-3 in Normal and Malignant Thyroid Tissue by Quantitative PCR and Immunohistochemistry , 2003, Modern Pathology.
[5] Arie Perry,et al. Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.
[6] S. Asa. My approach to oncocytic tumours of the thyroid , 2004, Journal of Clinical Pathology.
[7] F. Iida. Thyroid Carcinoma , 1991, Pediatrics In Review.
[8] Karl Kornacker,et al. Chipping away at the chip bias: RNA degradation in microarray analysis , 2003, Nature Genetics.
[9] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Fagin. Perspective: Lessons Learned from Molecular Genetic Studies of Thyroid Cancer-Insights into Pathogenesis and Tumor-Specific Therapeutic Targets. , 2002, Endocrinology.
[11] M. Niedziela,et al. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. , 2002, The Journal of clinical endocrinology and metabolism.
[12] N. Seidah,et al. Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. , 2004, The American journal of pathology.
[13] G. Fontanini,et al. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens. , 2003, Thyroid : official journal of the American Thyroid Association.
[14] A. Vecchione,et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions , 2001, The Lancet.
[15] W H Wong,et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[16] Jeffrey E. Lee,et al. Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. , 2003, American journal of surgery.
[17] D. Segev,et al. Molecular pathogenesis of thyroid cancer. , 2003, Surgical oncology.
[18] C. Lohse,et al. Observer Variation in the Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma , 2004, The American journal of surgical pathology.
[19] S. Libutti,et al. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. , 2004, Cancer research.
[20] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] P. V. van Diest,et al. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. , 2000, The American journal of pathology.
[22] H. Gharib,et al. Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas. , 2001, Thyroid : official journal of the American Thyroid Association.
[23] Christian Pilarsky,et al. WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer , 2003, The Journal of pathology.
[24] B. Jones,et al. Analysis of inconclusive fine-needle aspiration of thyroid follicular lesions , 2003, Endocrine pathology.
[25] C. Barden,et al. Discrimination of Benign and Malignant Thyroid Nodules by Molecular Profiling , 2004, Annals of surgery.
[26] C Eng,et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Barden,et al. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] Robert H. Silverman,et al. Activation of the interferon system by short-interfering RNAs , 2003, Nature Cell Biology.
[29] V. Vasko,et al. Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer , 2004, Journal of Medical Genetics.
[30] M. Welker,et al. Thyroid nodules. , 2003, American family physician.
[31] G. Chiappetta,et al. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. , 2002, The Journal of clinical endocrinology and metabolism.
[32] D. Fraker,et al. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. , 2003, Surgery.
[33] S. Liyanarachchi,et al. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Y. Takano,et al. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis , 1999, The Journal of pathology.
[35] Charis Eng,et al. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. , 2003, Cancer research.
[36] J. Minna,et al. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] D. Ross. Nonpalpable thyroid nodules--managing an epidemic. , 2002, The Journal of clinical endocrinology and metabolism.
[38] K. Unsicker,et al. Growth Differentiation Factor-15 Prevents Low Potassium-induced Cell Death of Cerebellar Granule Neurons by Differential Regulation of Akt and ERK Pathways* , 2003, The Journal of Biological Chemistry.
[39] J. Shah,et al. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays. , 2002, The American journal of pathology.
[40] S. Goodman,et al. Human Telomerase Reverse Transcriptase Gene Expression and the Surgical Management of Suspicious Thyroid Tumors , 2004, Clinical Cancer Research.
[41] Shinichiro,et al. Carcinoma , 1906, The Hospital.
[42] D. Clark,et al. Beyond the suspicious thyroid fine needle aspirate. A review. , 2003, Acta cytologica.
[43] Jennifer Shoemaker,et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. , 2004, The Journal of clinical investigation.
[44] T. Fahey,et al. 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(7):3214–3223 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-031811 Molecular Profiling Distinguishes Papillary Carcinoma , 2022 .
[45] H. Vierhapper,et al. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. , 2000, Thyroid : official journal of the American Thyroid Association.
[46] S. Sukumar,et al. Human Telomerase Reverse Transcriptase ( hTERT ) Gene Expression in Thyroid Neoplasms 1 , 1999 .
[47] B. Kinder. Well differentiated thyroid cancer , 2003, Current opinion in oncology.
[48] K. Schmid,et al. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas? , 2003, Surgery.
[49] P. Malfertheiner,et al. Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer , 2003, British Journal of Cancer.
[50] C. Plass,et al. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. , 2005, The Journal of clinical endocrinology and metabolism.
[51] C. Morrison,et al. Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas , 2003, Oncogene.
[52] O. Clark,et al. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. , 2004, Thyroid : official journal of the American Thyroid Association.
[53] P. De Giuli,et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. , 2001, The Journal of clinical endocrinology and metabolism.
[54] T. Takano,et al. High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas , 2004, British Journal of Cancer.
[55] K. Kinzler,et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.